FDA Fast Tracks First Possible Treatment for Familial Adenomatous Polyposis

In late September, Food and Drug Administration designated "fast track" status to the research and development of CPP-1X/sul for adults diagnosed with Familial Adenomatous Polyposis (FAP). Overseeing the project are Cancer…

Continue Reading FDA Fast Tracks First Possible Treatment for Familial Adenomatous Polyposis